Td Asset Management Inc Royalty Pharma PLC Transaction History

Td Asset Management Inc

$108 Billion
Q2 2025

A detailed history of Td Asset Management Inc transactions in Royalty Pharma PLC stock. As of the latest transaction made, Td Asset Management Inc holds 103,066 shares of RPRX stock, worth $3.75 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

103,066

Previous 83,211 23.86%

Holding current value

$3.75 Million

Previous $2.59 Million 43.36%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 28, 2025	BUY	$30.85 - $36.14 $612,526 - $717,559	19,855 Added 23.86%	103,066 $3.71 Million
Q1 2025 May 07, 2025	BUY	$25.75 - $33.86 $713,738 - $938,531	27,718 Added 49.95%	83,211 $2.59 Million
Q4 2024 Feb 11, 2025	BUY	$24.28 - $28.39 $254,915 - $298,066	10,499 Added 23.33%	55,493 $1.42 Million
Q3 2024 Nov 01, 2024	BUY	$25.63 - $29.27 $21,067 - $24,059	822 Added 1.86%	44,994 $1.27 Million
Q2 2024 Aug 02, 2024	SELL	$26.26 - $29.9 $653,348 - $743,912	-24,880 Reduced 36.03%	44,172 $1.16 Million
Q1 2024 May 08, 2024	SELL	$27.46 - $31.33 $4.15 Million - $4.73 Million	-151,131 Reduced 68.64%	69,052 $2.1 Million
Q4 2023 Feb 12, 2024	SELL	$26.21 - $29.22 $1.84 Million - $2.05 Million	-70,300 Reduced 24.2%	220,183 $6.18 Million
Q3 2023 Oct 27, 2023	BUY	$26.26 - $31.38 $2.52 Million - $3.01 Million	96,026 Added 49.38%	290,483 $7.88 Million
Q2 2023 Aug 09, 2023	SELL	$29.6 - $36.56 $232,537 - $287,215	-7,856 Reduced 3.88%	194,457 $5.98 Million
Q1 2023 May 10, 2023	BUY	$32.77 - $39.4 $32,638 - $39,242	996 Added 0.49%	202,313 $7.29 Million
Q4 2022 Feb 06, 2023	BUY	$39.17 - $44.04 $387,312 - $435,467	9,888 Added 5.17%	201,317 $7.96 Million
Q3 2022 Nov 07, 2022	SELL	$39.88 - $44.65 $572,198 - $640,638	-14,348 Reduced 6.97%	191,429 $7.72 Million
Q2 2022 Aug 04, 2022	BUY	$37.53 - $44.22 $1.42 Million - $1.67 Million	37,742 Added 22.46%	205,777 $8.65 Million
Q1 2022 May 10, 2022	BUY	$37.46 - $42.44 $23,524 - $26,652	628 Added 0.38%	168,035 $6.55 Million
Q4 2021 Feb 10, 2022	BUY	$35.17 - $42.48 $454,220 - $548,629	12,915 Added 8.36%	167,407 $6.67 Million
Q3 2021 Nov 09, 2021	SELL	$36.14 - $42.24 $36,140 - $42,240	-1,000 Reduced 0.64%	154,492 $5.58 Million
Q2 2021 Aug 11, 2021	BUY	$39.85 - $46.63 $99,625 - $116,575	2,500 Added 1.63%	155,492 $5.94 Million
Q1 2021 May 14, 2021	BUY	$42.34 - $52.82 $245,572 - $306,356	5,800 Added 3.94%	152,992 $6.67 Million
Q4 2020 Feb 16, 2021	SELL	$36.12 - $50.05 $4.03 Million - $5.59 Million	-111,699 Reduced 43.15%	147,192 $7.37 Million
Q3 2020 Nov 10, 2020	BUY	$38.56 - $48.36 $2.7 Million - $3.39 Million	70,000 Added 37.06%	258,891 $10.9 Million
Q2 2020 Aug 13, 2020	BUY	$44.5 - $52.11 $8.41 Million - $9.84 Million	188,891 New	188,891 $9.17 Million

Others Institutions Holding RPRX

# of Institutions

497

Shares Held

307M

Call Options Held

1.99M

Put Options Held

384K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $15.9B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Account

Td Asset Management Inc Royalty Pharma PLC Transaction History